U 135 white oval pill

If you are a consumer or patient please visit this version.

If you are a consumer or patient please visit this version. History of a hypersensitivity reaction to clonidine. Reactions have included generalized rash, urticaria, angioedema. Clonidine hydrochloride extended-release tablets are indicated for the treatment of attention deficit hyperactivity disorder ADHD as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies 14 ]. Clonidine hydrochloride extended-release tablets are an extended-release tablet to be taken orally with or without food. Swallow tablets whole. Do not crush, chew, or break tablets because this will increase the rate of clonidine release.

U 135 white oval pill

.

Teratogenic Effects : Pregnancy Category C. Product Characteristics. Clonidine hydrochloride, USP is a centrally acting alpha-agonist hypotensive agent available as tablets for oral administration in three dosage strengths: 0.

.

If you are a consumer or patient please visit this version. Clonidine hydrochloride, USP is a centrally acting alpha-agonist hypotensive agent available as tablets for oral administration in three dosage strengths: 0. The 0. The inactive ingredients are colloidal silicon dioxide, corn starch, dibasic calcium phosphate, sodium starch glycolate, glycerin, lactose monohydrate, magnesium stearate, povidone. Clonidine hydrochloride is an imidazoline derivative and exists as a mesomeric compound. The chemical name is 2- 2,6-dichlorophenylamino imidazoline hydrochloride. The following is the structural formula:. Clonidine hydrochloride is an odorless, bitter, white, crystalline substance soluble in water and alcohol.

U 135 white oval pill

Go PRO to access past versions. Teratogenic Effects: Pregnancy Category C Reproduction studies performed in rabbits at doses up to approximately 3 times the oral maximum recommended daily human dose MRDHD of clonidine hydrochloride tablets produced no evidence of a teratogenic or embryotoxic potential in rabbits. Increased resorptions were not associated with treatment at the same time or at higher dose levels up to 3 times the oral MRDHD when the dams were treated on gestation days 6 to No adequate, well-controlled studies have been conducted in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. As clonidine hydrochloride is excreted in human milk, caution should be exercised when clonidine hydrochloride tablets are administered to a nursing woman. Go PRO for all pill images. Rx only. Clonidine hydrochloride, USP is a centrally acting alpha-agonist hypotensive agent available as tablets for oral administration in three dosage strengths: 0. The 0.

Polish airlines

This Patient Information leaflet does not take the place of talking to your doctor about your medical condition or treatment. These are not all of the possible side effects of clonidine hydrochloride extended-release tablets. The purpose of the registry is to collect information about the health of females exposed to clonidine hydrochloride and their baby. White round shaped, biconvex, scored tablets, debossed with "U" and "" on either side of breakline on one side and plain on other side. Preferred Term. Reactions have included generalized rash, urticaria, angioedema. NDC 1 2 3 Clonidine hydrochloride, USP is a centrally acting alpha-agonist hypotensive agent available as tablets for oral administration in three dosage strengths: 0. Patients were randomly assigned to one of the following three treatment groups: clonidine hydrochloride extended-release tablets CLON 0. The dose of clonidine hydrochloride tablets must be adjusted according to the patient's individual blood pressure response. What should I tell my doctor before taking clonidine hydrochloride extended-release tablets? Because children commonly have gastrointestinal illnesses that lead to vomiting, they may be particularly susceptible to hypertensive episodes resulting from abrupt inability to take medication.

It is advised to take this medication orally as directed by your doctor.

Following intravenous administration, clonidine displays biphasic disposition with a distribution half-life of about 20 minutes and an elimination half-life ranging from 12 to 16 hours. Studies have indicated that 2. Do not use clonidine hydrochloride extended-release tablets for a condition for which it was not prescribed. Clonidine hydrochloride tablets are indicated in the treatment of hypertension. Clonidine hydrochloride is an imidazoline derivative and exists as a mesomeric compound. There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to ADHD medications, including clonidine hydrochloride, during pregnancy. Due to the lack of controlled clinical trial data and differing pharmacokinetic profiles, substitution of clonidine hydrochloride extended-release tablets for other clonidine products on a mg-per-mg basis is not recommended [see Clinical Pharmacology Sedation and Somnolence Instruct patients to use caution when driving a car or operating hazardous machinery until they know how they will respond to treatment with clonidine hydrochloride extended-release tablets. Hematologic: Thrombocytopenia. Your doctor may prescribe clonidine hydrochloride extended-release tablets alone or together with certain other ADHD medicines. At both doses, improvements in ADHD symptoms were statistically significantly superior in clonidine hydrochloride extended-release tablets-treated patients compared with placebo-treated patients at the end of 5 weeks as measured by the ADHDRS-IV total score Table 8. Your doctor will tell you how many clonidine hydrochloride extended-release tablets to take and when to take them. Fertility Advise females and males of reproductive potential that clonidine hydrochloride may impair fertility [see Use in Specific Populations 8. Tell your doctor about all of the medicines that you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. In adults with hypertension, sudden cessation of treatment with immediate-release clonidine has, in some cases, resulted in symptoms such as nervousness, agitation, headache, and tremor accompanied or followed by a rapid rise in blood pressure and elevated catecholamine concentrations in the plasma.